These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20551453)

  • 1. Autoantibodies in autoimmune liver disease: biomarkers versus epiphenomena.
    Selmi C; Gershwin ME
    Gut; 2010 Jun; 59(6):712-3. PubMed ID: 20551453
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antineutrophil cytoplasmatic antibodies and their diagnostic significance as serum markers].
    Terjung B; Spengler U; Sauerbruch T
    Dtsch Med Wochenschr; 1999 Nov; 124(44):1314-20. PubMed ID: 10596294
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmune hepatitis in inflammatory bowel disease: report of two unusual cases.
    Seibold F; Weber P; Jenss H; Scheurlen M
    Z Gastroenterol; 1997 Jan; 35(1):29-32. PubMed ID: 9123955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations].
    Montes Santiago J; Gambón Deza F; García García MJ; González Vázquez L; Hermo Brión JA; Pérez Alvarez R
    An Med Interna; 2000 Jul; 17(7):343-6. PubMed ID: 10981329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].
    Folwaczny C; Fricke H
    Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690
    [No Abstract]   [Full Text] [Related]  

  • 7. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
    Hartman C; Eliakim R; Shamir R
    Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
    [No Abstract]   [Full Text] [Related]  

  • 8. [Can we predict autoimmune disease of the gastrointestinal tract and the liver by autoantibodies].
    Israeli E; Shoenfeld Y
    Harefuah; 2007 Jan; 146(1):28-31. PubMed ID: 17294845
    [No Abstract]   [Full Text] [Related]  

  • 9. ANCA--diagnostic markers or pathogenic agents?
    Jennette JC; Falk RJ
    Bull Rheum Dis; 1992; 41(8):3-6. PubMed ID: 1472959
    [No Abstract]   [Full Text] [Related]  

  • 10. [Autoantibodies in hepatology].
    Johanet C; Dubel L; Chazouillères O
    Pathol Biol (Paris); 1999 Nov; 47(9):997-1005. PubMed ID: 10609280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tha markers of secondary uveitis].
    Bosch X
    Med Clin (Barc); 1998 Dec; 111(20):798-9. PubMed ID: 9922973
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].
    Desreumaux P; Bourreille A; Colombel JF
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S81-6. PubMed ID: 12704300
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of autoantibodies in clinical practice].
    Petitpierre S; Aubert V; Leimgruber A; Spertini F; Bart PA
    Rev Med Suisse; 2009 Apr; 5(199):823-31. PubMed ID: 19441748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic biomarkers for autoimmune disease.
    Hueber W; Robinson WH
    Proteomics; 2006 Jul; 6(14):4100-5. PubMed ID: 16786488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic autoantibodies (ANCA)--markers in diagnosis and monitoring systemic vasculitides.
    Cristea A; Badea T; Bodizs G; Olinic N
    Rom J Intern Med; 1995; 33(1-2):37-46. PubMed ID: 8535351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibodies: clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing.
    Ecklund SR; Saluta GS; Agudelo CA; Pisko EJ
    South Med J; 1992 Feb; 85(2):132-8. PubMed ID: 1738878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antineutrophil cytoplasmic antibodies in chronic inflammatory bowel diseases].
    Schlenker T; Apenberg S; Raedsch R; Andrassy K; Plachky J; Kommerell B
    Dtsch Med Wochenschr; 1992 Sep; 117(39):1463-8. PubMed ID: 1396127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of autoantibodies.
    Herkel J; Lohse AW
    Hepatology; 2008 Mar; 47(3):786-8. PubMed ID: 18302295
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical laboratory in the diagnosis of autoimmune liver diseases].
    Muñoz LE; del Rocío Ayala SR
    Rev Gastroenterol Mex; 1993; 58(2):164-9. PubMed ID: 7747027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serological markers in inflammatory bowel disease: differences among populations and limitations of their application].
    Barahona-Garrido J; Hernández-Calleros J; Sarti HM; Cabiedes J; Yamamoto-Furusho JK
    Gastroenterol Hepatol; 2009 May; 32(5):380-1. PubMed ID: 19457592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.